Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)

Author(s):  Whaley Paul A, Voudrie Mark A II, Sorenson Bridget

Issue:  Mar/Apr 2012 - Volume 16, Number 2
View All Articles in Issue

Abstract:  Omeprazole is used in the treatment of dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger–Ellison syndrome. Omeprazole is marketed by AstraZeneca under a number of names, most notably Prilosec and Losec, as well as being available from a number of generic manufacturers. Omeprazole is available in both tablet and capsule form, with varying strengths of each. The need for other administration options for those patients who cannot take tablets or capsules has led compounding pharmacies to seek other alternatives. One possible alternative is the use of a suspending agent to create an oral solution or suspension. In the past, this has been accomplished using a sodium bicarbonate solution as the vehicle. However, sodium bicarbonate/omeprazole combination imparts a bitter and unpleasant taste. SyrSpend SF Alka (reconstituted) is a vehicle for making a suspension which has a pleasant taste, thus increasing palpability and compliance. The objective of this study was to determine the stability of omeprazole in SyrSpend SF Alka (for reconstitution). The studied sample was compounded into a 2-mg/mL suspension and stored in a low-actinic plastic prescription bottle at temperatures between 2oC and 8oC. Six samples were assayed at each time point out to 92 days by a stability-indicating high-performance liquid chromatography method. The method was validated for its specificity through forced degradation studies. The shelf life of this product is at least 92 days, based on data collected when refrigerated and protected from light.

Related Keywords: Paul A. Whaley, BS, Mark A. Voudrie II, MS, PMP, Bridget Sorensen, CAPM, omeprazole, peptic ulcer disease, gastroesophageal reflux disease, GERD, dyspepsia, suspension, stability


Printer-Friendly Version

Download in electronic PDF format for $65

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Whaley Paul A, Voudrie Mark A II, Sorenson Bridget Mar/Apr 2012 164-166 Buy
The Treatment of Canine Atopic Disease Davidson Gigi S May/Jun 2002 210-215 Buy
Basics of Compounding for Raynaud's Disease Glasnapp Andrew Jul/Aug 2003 288-291 Buy
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Corsini Lindsay, Williams LaVonn A Mar/Apr 2011 124-128 Buy
Stability of Propranolol Hydrochloride in SyrSpend SF Geiger Christine M, Voudrie Mark A II, Sorenson Bridget Nov/Dec 2012 513-515 Buy
Stability of Ursodiol in SyrSpend SF Cherry Flavored Geiger Christine M, Voudrie Mark A II, Sorenson Bridget Nov/Dec 2012 510-512 Buy
Stability of Gabapentin in SyrSpend SF Sorenson Bridget, Voudrie Mark A II, Gehrig Dan Jul/Aug 2012 347-349 Buy
Treating Canine Hepatic Disease Davidson Gigi S May/Jun 2003 188-191 Buy
Stability of Vancomycin in SyrSpend SF Whaley Paul A, Voudrie Mark A II Mar/Apr 2012 167-169 Buy
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Voudrie Mark A, Alexander Bridget, Allen D Brett May/Jun 2011 255-258 Buy
Particle Measuring Systems - USP <797> Environmental Monitoring Solutions